We’re excited to announce that Axent Bio will be participating in the 2025 ISSCR International Symposium in Boston, hosted by the International Society for Stem Cell Research.
We’re proud to announce that Axent Bio has been selected to present at the 2025 Meeting on the Mesa, one of the leading conferences for cell and gene therapy innovation.
Axent Bio Welcomes Samantha Smith and Sungmin Kim to the team as 2025 QWEST Interns working in the Analytical Development and Process Development Teams
We’re excited to announce that Axent Bio has been awarded a Translational Award from the California Institute for Regenerative Medicine (CIRM) to advance our scalable cell therapy platform for Parkinson’s disease.
In a recent interview with Alejandro Cremades, Axent Bio co-founder David Schaffer shared his journey from academic scientist to serial biotech entrepreneur.